Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adult MSC for Bone Regeneration and Osseointegration after Sinus Augmentation
2006-003551-20Phase 2Completed
- Sponsor
- Department of Oral Surgery, Medical University of Graz
- Start
- May 2007
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous mesenchymal stem cells in edentulism and Maxillary alveolar bone atrophy (2 arms), sponsored by Department of Oral Surgery, Medical University of Graz. Primary endpoints: Osseointegration of dental implants and Bone regeneration in the maxilla. Started May 2007; status: completed.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
edentulismMaxillary alveolar bone atrophy
Beyond the preview
Go deeper on 2006-003551-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003551-20.